Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Anti PD-1 Neo-adjuvant Treatment for Early Stage NSCLC - Phase I Study

NCT02938624 is registered in ClinicalTrials.gov with Jair Bar, M.D., Ph.D. as lead sponsor.

NCT NCT02938624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02938624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Anti PD-1 Neo-adjuvant Treatment for Early Stage NSCLC - Phase I Study
Lead sponsor
Jair Bar, M.D., Ph.D.
Phase
Phase 1
Overall status
Completed
Start date
January 7, 2017
Completion date
August 31, 2021
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung carcinoma, stage i, stage ii